EcoDrugPlus

Ensembl ID : ENSLACG00000017435
Gene Symbol: -
Cross references: -
317 Possible Orthologues:

Ensembl ID : ENSLACG00000011485
Gene Symbol: -
Cross references: -
275 Possible Orthologues:

Ensembl ID : ENSLACG00000003788
Gene Symbol: RPL34
1 Cross references
364 Possible Orthologues:

Ensembl ID : ENSLACG00000012237
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Ensembl ID : ENSLACG00000016753
Gene Symbol: NTRK3
1 Cross references
268 Possible Orthologues:

Ensembl ID : ENSLACG00000017201
Gene Symbol: -
Cross references: -
268 Possible Orthologues:

Ensembl ID : ENSLACG00000017443
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSLACG00000017820
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSLACG00000004526
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSLACG00000004454
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSLACG00000008003
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSLACG00000008679
Gene Symbol: -
Cross references: -
449 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).